AUTHOR=Mao Gai , Li Yue , Li Min , Wang Jin , Li Ying 

TITLE=Machine learning prediction of feeding intolerance in preterm infants: a pre-feeding risk stratification model

JOURNAL=Frontiers in Pediatrics

VOLUME=Volume 13 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2025.1646973

DOI=10.3389/fped.2025.1646973

ISSN=2296-2360

ABSTRACT=BackgroundFeeding intolerance (FI) represents a prevalent and serious complication in preterm infants, contributing to delayed enteral nutrition, prolonged hospitalization, and increased morbidity. Early identification of high-risk infants remains challenging due to limited predictive tools available before feeding initiation.MethodsWe conducted a retrospective cohort study of 402 preterm infants (<37 weeks gestational age) admitted between January 2023 and May 2024. Clinical data collected at admission underwent feature selection using cross-validated LASSO regression. Eleven machine learning algorithms were systematically compared using accuracy, area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. Clinical utility was assessed through decision curve analysis (DCA).ResultsFI developed in 199 (49.5%) infants. Significant between-group differences were observed for birth weight, gestational age, time to first feeding, fetal distress, multiple gestation, prenatal dexamethasone exposure, neonatal infection, respiratory distress, and invasive mechanical ventilation (all P < 0.01). LASSO regression identified 14 optimal predictive variables. Among tested algorithms, AdaBoost demonstrated superior performance [accuracy: 0.957; AUC: 0.964 (95% CI: 0.929–1.000); sensitivity: 0.957; specificity: 0.958]. DCA confirmed greater net clinical benefit compared to “treat all” or “treat none” strategies. An interactive clinical decision support tool was developed for practical implementation.ConclusionsThe proposed machine learning model accurately predicts feeding intolerance before first feeding using 14 routinely collected clinical variables. This approach enables early risk stratification and may improve clinical outcomes through timely intervention. External validation in multicenter cohorts is warranted to confirm generalizability.